Related references
Note: Only part of the references are listed.Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type II Due to a Mutation in Plasmid-Borne blakpc-2 to blakpc-33, in Henan, China
Debao Li et al.
INFECTION AND DRUG RESISTANCE (2021)
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies
Stefano Di Bella et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
P. Zhang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the bla KPC3 gene
E. Antinori et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam
I. Galani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
Peera Hemarajata et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues
Alberto Antonelli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime/avibactam
Carolina Venditti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility
L. Silvia Munoz-Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
Stephan Goettig et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Infections by multidrug- resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
Despoina Koulenti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Public health burden of antimicrobial resistance in Europe
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2019)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
Antoni Torres et al.
LANCET INFECTIOUS DISEASES (2018)
Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype
Mariana Castanheira et al.
MSPHERE (2018)
Carbapenemase-Producing Organisms: A Global Scourge
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2018)
Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
Marla J. Giddins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
Elizabeth Temkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
Ryan K. Shields et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
Kirk Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2016)
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vitro Selection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV beta-lactamases with single amino acid substitutions in the Omega-loop
Marisa L. Winkler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Antimicrobial resistance: a global multifaceted phenomenon
Francesca Prestinaci et al.
PATHOGENS AND GLOBAL HEALTH (2015)
Multiplex real-time PCR probe-based for identification of strains producing: OXA48, VIM, KPC and NDM
Marco Favaro et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2014)
P70 Detection of plasmid mediated KPC-producing Klebsiella pneumo-niae in Ottawa, Canada: evidence of intra-hospital transmission
D. Goldfarb et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene
Thierry Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outbreak of Klebsiella pneumoniae producing a new carbapenern hydrolyzing class a β-lactamase, KPC-3, in a New York Medical Center
N Woodford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)